Zinc oxinate

N/A

Report date: 2023/01/16 10:11:21
NME

Base Information

Drug NameZinc oxinate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsKeratosis, ActinicCarcinoma, Squamous CellCarcinoma, Basal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesDermex Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDermex Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsKeratosis, ActinicCarcinoma, Squamous CellCarcinoma, Basal Cell

Other Information

ATC CodeN/A
Related LinksN/A